Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 3,4 Dihydroquinazolin 2 one. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111533701B reveals a novel nitrobenzene-based route for pyridine quinazoline intermediates, offering significant cost reduction and safer manufacturing for agrochemical suppliers.
Novel route for 3-amino-6-(perfluoropropane-2-yl)-3,4-dihydroquinazolin-2(1H)-one offering high purity and cost efficiency for insecticide production.
Novel organophosphine-catalyzed asymmetric [4+2] cycloaddition for high-purity chiral 3,4-dihydroquinazolin-2-ones. Scalable route with excellent enantioselectivity up to 92% ee.